Macrophage migration inhibitory factor (MIF)

The protein contains 115 amino acids for an estimated molecular weight of 12476 Da.

 

Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of macrophages in host defense. Counteracts the anti-inflammatory activity of glucocorticoids. Has phenylpyruvate tautomerase and dopachrome tautomerase activity (in vitro), but the physiological substrate is not known. It is not clear whether the tautomerase activity has any physiological relevance, and whether it is important for cytokine activity. (updated: April 1, 2015)

Protein identification was indicated in the following studies:

  1. Goodman and co-workers. (2013) The proteomics and interactomics of human erythrocytes. Exp Biol Med (Maywood) 238(5), 509-518.
  2. Lange and co-workers. (2014) Annotating N termini for the human proteome project: N termini and Nα-acetylation status differentiate stable cleaved protein species from degradation remnants in the human erythrocyte proteome. J Proteome Res. 13(4), 2028-2044.
  3. Hegedűs and co-workers. (2015) Inconsistencies in the red blood cell membrane proteome analysis: generation of a database for research and diagnostic applications. Database (Oxford) 1-8.
  4. Bryk and co-workers. (2017) Quantitative Analysis of Human Red Blood Cell Proteome. J Proteome Res. 16(8), 2752-2761.
  5. D'Alessandro and co-workers. (2017) Red blood cell proteomics update: is there more to discover? Blood Transfus. 15(2), 182-187.

Methods

The following articles were analysed to gather the proteome content of erythrocytes.

The gene or protein list provided in the studies were processed using the ID mapping API of Uniprot in September 2018. The number of proteins identified and mapped without ambiguity in these studies is indicated below.
Only Swiss-Prot entries (reviewed) were considered for protein evidence assignation.

PublicationIdentification 1Uniprot mapping 2Not mapped /
Obsolete
TrEMBLSwiss-Prot
Goodman (2013)2289 (gene list)227853205992269
Lange (2014)123412347281224
Hegedus (2015)2638262202352387
Wilson (2016)165815281702911068
d'Alessandro (2017)18261817201815
Bryk (2017)20902060101081942
Chu (2018)18531804553621387

1 as available in the article and/or in supplementary material
2 uniprot mapping returns all protein isoforms as one entry

The compilation of older studies can be retrieved from the Red Blood Cell Collection database.

The data and differentiation stages presented below come from the proteomic study and analysis performed by our partners of the GReX consortium, more details are available in their published work.

No sequence conservation computed yet.

This protein is annotated as membranous in Gene Ontology.


Interpro domains
Total structural coverage: 100%
Model score: 100
No model available.

(right-click above to access to more options from the contextual menu)

Biological Process

Carboxylic acid metabolic process GO Logo
Cell aging GO Logo
Cell population proliferation GO Logo
Cell surface receptor signaling pathway GO Logo
DNA damage response, signal transduction by p53 class mediator GO Logo
Inflammatory response GO Logo
Innate immune response GO Logo
Interleukin-12-mediated signaling pathway GO Logo
Leukocyte migration GO Logo
Negative regulation of apoptotic process GO Logo
Negative regulation of cell aging GO Logo
Negative regulation of cell cycle arrest GO Logo
Negative regulation of cell migration GO Logo
Negative regulation of cellular protein metabolic process GO Logo
Negative regulation of DNA damage response, signal transduction by p53 class mediator GO Logo
Negative regulation of gene expression GO Logo
Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator GO Logo
Negative regulation of macrophage chemotaxis GO Logo
Negative regulation of mature B cell apoptotic process GO Logo
Negative regulation of myeloid cell apoptotic process GO Logo
Neutrophil degranulation GO Logo
Positive chemotaxis GO Logo
Positive regulation of arachidonic acid secretion GO Logo
Positive regulation of B cell proliferation GO Logo
Positive regulation of chemokine (C-X-C motif) ligand 2 production GO Logo
Positive regulation of cytokine production GO Logo
Positive regulation of cytokine secretion GO Logo
Positive regulation of ERK1 and ERK2 cascade GO Logo
Positive regulation of fibroblast proliferation GO Logo
Positive regulation of lipopolysaccharide-mediated signaling pathway GO Logo
Positive regulation of MAP kinase activity GO Logo
Positive regulation of myeloid leukocyte cytokine production involved in immune response GO Logo
Positive regulation of peptidyl-serine phosphorylation GO Logo
Positive regulation of peptidyl-tyrosine phosphorylation GO Logo
Positive regulation of phosphorylation GO Logo
Positive regulation of prostaglandin secretion involved in immune response GO Logo
Positive regulation of protein kinase A signaling GO Logo
Positive regulation of tumor necrosis factor production GO Logo
Prostaglandin biosynthetic process GO Logo
Protein homotrimerization GO Logo
Regulation of macrophage activation GO Logo

The reference OMIM entry for this protein is 153620

Macrophage migration inhibitory factor; mif
Mmif

CLONING

Migration inhibitory factor for guinea pig macrophages was the first lymphokine to be discovered (Bloom and Bennett, 1966; David, 1966). Expression of MIF activity was found to correlate well with delayed hypersensitivity and cellular immunity in humans. MIF activity could be detected in the synovia of patients with rheumatoid arthritis. The expression of MIF at sites of inflammation suggested a role for the mediator in regulating the function of macrophages in host defense. Weiser et al. (1989) isolated a cDNA encoding human macrophage migration inhibitory factor. By Northern blot analysis, Paralkar and Wistow (1994) demonstrated a single size of MIF mRNA (about 800 nucleotides) in all human tissues examined. In contrast to previous reports, they found no evidence for multiple genes for MIF in the human genome.

GENE STRUCTURE

Paralkar and Wistow (1994) showed that the MIF gene is remarkably small; it has 3 exons separated by introns of only 189 and 95 bp, and covers less than 1 kb. Kozak et al. (1995) found that the exon/intron structure of the mouse Mif gene resembles that of the human gene. Bozza et al. (1995) found that the mouse Mif gene spans less than 0.7 kb of chromosomal DNA and is composed of 3 exons. Esumi et al. (1998) presented evidence that the gene for D-dopachrome tautomerase (DDT; 602750) in human and mouse is identical in exon structure to MIF. Both genes have 2 introns that are located at equivalent positions, relative to a 2-fold repeat in protein structure. Although in similar positions, the introns are in different phases relative to the open reading frame. Other members of this superfamily exist in nematodes and a plant, and a related gene in C. elegans shares an intron position with MIF and DDT. In addition to similarities in structure, the genes for DDT and MIF are closely linked on human chromosome 22 and mouse chromosome 10.

GENE FUNCTION

Bernhagen et al. (1993) identified MIF as a major secreted protein released by anterior pituitary cells in culture and in vivo in response to stimulation with bacterial lipopolysaccharide. They concluded that it plays a central role in the toxic response to endotoxemia and possibly septic shock. Bucala (1996) reviewed studies that led to the discovery of a pituitary mediator that appeared to act as the counter-regulatory hormone for glucocorticoid action within the immune system. Isolated as a product of murine anterior pituitary cells, this peptide was sequenced and found to be the mouse homolog of MIF. MIF has the unique property of being released from macrophages and T cells in response to physiologic concentrations of glucocorticoids. The secretion of MIF is tightly regulated and decreases at high, antiinflammatory steroid concentrations. Once released, MIF 'overrides' or counter-regulates the immunosuppressive effects of steroids on immune cell activation and cytokine production. Bucala (1996) stated that because glucocorticoids are an integral part of the host's global response to infection or tissue invasion, the physiologic role of MIF is to act at an inflammatory site or lymph node to counterbalance the profound inhibitory effect of steroids on the immune response. Using full-length MIF as bait in a yeast 2-hybrid screen of a brain cDNA library, Kleemann et al. (2000) captured Jun activation domain-binding protein (JAB1, or COPS5; 604850) as an interacting partner of MIF. By coimmunoprecipitation and pull-down experiments, Kle ... More on the omim web site

Subscribe to this protein entry history

Feb. 2, 2018: Protein entry updated
Automatic update: Uniprot description updated

Dec. 19, 2017: Protein entry updated
Automatic update: Uniprot description updated

Nov. 23, 2017: Protein entry updated
Automatic update: Uniprot description updated

March 16, 2016: Protein entry updated
Automatic update: OMIM entry 153620 was added.

Jan. 28, 2016: Protein entry updated
Automatic update: model status changed

Jan. 24, 2016: Protein entry updated
Automatic update: model status changed